RBI Aktienanleihe PAL 26.03.2025/ AT0000A39PP9 /
10/06/2024 9:15:01 | Diferencia-0.46 | Bid13:00:52 | Ask13:00:52 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
100.66EUR | -0.45% | 100.62 Volumen de oferta: 50,000 |
100.87 Tamaño/ Volumen/ Formato de Ask: 50,000 |
Palfinger AG | 25.00 EUR | 26/03/2025 | Call |
GlobeNewswire
14:40
SELLAS Announces Completion of Enrollment and Initial Positive Data in Phase 2a Trial of SLS009 in r...
GlobeNewswire
14:35
IBN Announces Latest Episode of The Bell2Bell Podcast featuring Stormer Santana, Director of Sales a...
GlobeNewswire
14:32
Publication of an article in Nature's Scientific Reports describing the quantification of novel radi...
GlobeNewswire
14:30
NewtekOne, Inc. CEO, Barry Sloane, to Attend the 25th Annual KBW Community Bank Investor Conference ...
GlobeNewswire
14:30
Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patie...
GlobeNewswire
14:30
DFCU Financial Completes Acquisition of MidWestOne Bank’s Florida Operations in Naples and Fort Myer...
GlobeNewswire
14:30
C-Bond Systems Continues to Expand its Installation Base with more than 200 Schools, Commercial and ...
GlobeNewswire
14:30
SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company
GlobeNewswire
14:30
GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWG...
GlobeNewswire
14:30
RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
GlobeNewswire
14:30
Presentation at the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2024 Annual Meeting High...
GlobeNewswire
14:30
Optery Receives 2024 Intellyx Digital Innovator Award for Its Effectiveness At Reducing Security Inc...
GlobeNewswire
14:30
Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis (FAP) to be ...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página